Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by Accountprinceon Jan 08, 2021 10:58am
236 Views
Post# 32253651

Thumbs Down for management

Thumbs Down for managementI am only looking at the share action in the market today.  Prior to the SNN presentation yesterday the share price was rising up to the time for the presentation.  Went from around $0.40 per share to around $0.44 per share.  So it rose by 10% in anticipation of the presentation it would seem.  Presentation started after the market closed yesterday.

Today the volume is low (4,500 shares) and the price is down.  I would have thought it would rise.  On the surface it appears that Chris and Paul did not impress at all.  There is virtually no apparent interest that was garnered and it was broadcast to US interests.  This is really bad since Chris and Paul are the ones charged with executing the plan.  Perhaps they should rethink and bring in someone that can build the story and present it properly to the world.  It's a great story but needs some effective, captivating and wide ranging presentation.  Especially to the big market south of Canada.

For the benefit of all the shareholders.
<< Previous
Bullboard Posts
Next >>